Patents by Inventor Stephane Walrand

Stephane Walrand has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITION COMPRISING INULIN AND PROTEIN
    Publication number: 20220218737
    Abstract: The present invention relates to compositions comprising inulin and protein for reducing loss of muscle mass. The present invention also relates to a composition comprising inulin and protein, wherein said the ratio of said inulin to said protein is between 5/95 to 75/25 by weight. The present invention therefore also concerns the use of a composition comprising inulin and protein for the preparation of a food or a medicament.
    Type: Application
    Filed: May 22, 2020
    Publication date: July 14, 2022
    Applicant: Cosucra Groupe Warcoing S.A.
    Inventors: Heidi Jacobs, Jérome Salles, Stéphane Walrand, Cathy Signorot
  • USE OF CITRULLINE FOR TREATING UNDERNUTRITION CONDITIONS
    Publication number: 20100298437
    Abstract: The invention relates to the use of L-citrulline (I) or of one of its pharmaceutically acceptable salts in the preparation of a drug for the treatment of states or undernutrition as linked to a lowering of protein synthesis within the framework of pathologies which do not result from an intestinal insufficiency.
    Type: Application
    Filed: August 29, 2007
    Publication date: November 25, 2010
    Applicants: UNIVERSITE RENE DESCARTES-PARIS 5, BIOCODEX
    Inventors: Christophe Moinard, Marion Jourdan, Stephane Walrand, Luc Cynober
  • USE OF CITRULLINE FOR PREVENTING AN INCREASE IN PROTEIN CARBONYLATION AND FOR TREATING DISEASES RESULTING THEREFROM
    Publication number: 20100093863
    Abstract: A method of using L-citrulline of the formula (I) for preparing a cosmetic composition, a food or nutraceutic composition or a pharmaceutical composition for treating diseases related to an increase in protein carbonylation, in particular for treating neurodegenerative diseases such as Alzheimer's or Parkinson's disease.
    Type: Application
    Filed: March 20, 2008
    Publication date: April 15, 2010
    Applicants: UNIVERSITE PARIS DESCARTESURE, INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE, ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS, UNIVERSITE D' AUVERGNE
    Inventors: Christophe Moinard, Stephane Walrand, Yves Boirie, Luc Cynober